Loading
Latest filing published 12 Oct 2018 for Stellar Biotechnologies, Inc., €7,965.
Daniel E. Morse is a declared insider of Stellar Biotechnologies, Inc., with filings sourced from SEDI. Between 26 June 2017 and 12 October 2018, the trades on record add up to 8 filings.
Every open-market trade on record is a sale: 7 sales worth €32k. Besides market trades, the filings include 1 share grant. So far in 2018, the count stands at no purchases and 7 sales.
Most recently, on 12 October 2018, the filings show an open-market sale worth €7,965 in Stellar Biotechnologies, Inc. The median gap between a trade and its publication by SEDI is 5 days. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations